As shown in Fig. 8h, i, high levels of USP10 mRNA correlate with lower OS in the p53 mutant, but not in the p53 wild-type cohort, suggesting that USP10 is a potential target in a subset of NSCLC with p53 mutations. This evidence concerns the gene USP10 and non-small cell lung carcinoma.